HALO
Halozyme Therapeutics Inc.

4,822
Loading...
Loading...
Upcoming Earnings: Q3 '25
Reports: Oct 28,
After Hours

Estimated EPS

$1.63

Estimated Rev

$339.73M

Historical Earnings

Quarterly

Annual

EPS

Revenue

Fiscal PeriodEstimatedReportedSurpriseResult
Q3 '25
$1.63
--
--
N/A
Q2 '25
$1.24
$1.54
23.77%
BEAT
Q1 '25
$0.92
$1.11
20.18%
BEAT
Q4 '24
$1.13
$1.26
11.79%
BEAT
Q3 '24
$0.96
$1.27
32.57%
BEAT

Latest HALO News

View

Advertisement. Remove ads.

Advertisement. Remove ads.

Advertisement. Remove ads.